276 related articles for article (PubMed ID: 22594877)
1. Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation.
Das V; Miller JH
Eur J Neurosci; 2012 Jun; 35(11):1705-17. PubMed ID: 22594877
[TBL] [Abstract][Full Text] [Related]
2. Effect of taxoid and nontaxoid site microtubule-stabilizing agents on axonal transport of mitochondria in untransfected and ECFP-htau40-transfected rat cortical neurons in culture.
Das V; Sim DA; Miller JH
J Neurosci Res; 2014 Sep; 92(9):1155-66. PubMed ID: 24788108
[TBL] [Abstract][Full Text] [Related]
3. Non-taxoid site microtubule-stabilizing drugs work independently of tau overexpression in mouse N2a neuroblastoma cells.
Das V; Miller JH
Brain Res; 2012 Dec; 1489():121-32. PubMed ID: 23085090
[TBL] [Abstract][Full Text] [Related]
4. Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.
Wilmes A; Bargh K; Kelly C; Northcote PT; Miller JH
Mol Pharm; 2007; 4(2):269-80. PubMed ID: 17397239
[TBL] [Abstract][Full Text] [Related]
5. Delaying the onset of experimental autoimmune encephalomyelitis with the microtubule-stabilizing compounds, paclitaxel and Peloruside A.
Crume KP; O'Sullivan D; Miller JH; Northcote PT; La Flamme AC
J Leukoc Biol; 2009 Oct; 86(4):949-58. PubMed ID: 19654226
[TBL] [Abstract][Full Text] [Related]
6. Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Kanakkanthara A; Northcote PT; Miller JH
Nat Prod Rep; 2016 Apr; 33(4):549-61. PubMed ID: 26867978
[TBL] [Abstract][Full Text] [Related]
7. {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents.
Michaelis ML; Ansar S; Chen Y; Reiff ER; Seyb KI; Himes RH; Audus KL; Georg GI
J Pharmacol Exp Ther; 2005 Feb; 312(2):659-68. PubMed ID: 15375176
[TBL] [Abstract][Full Text] [Related]
8. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.
Gaitanos TN; Buey RM; Díaz JF; Northcote PT; Teesdale-Spittle P; Andreu JM; Miller JH
Cancer Res; 2004 Aug; 64(15):5063-7. PubMed ID: 15289305
[TBL] [Abstract][Full Text] [Related]
9. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling study on the differential microtubule-stabilizing effect in singly- and doubly-bonded complexes with peloruside A and paclitaxel.
Zúñiga MA; Alderete JB; Jaña GA; Navarrete KR; Jiménez VA
Proteins; 2019 Aug; 87(8):668-678. PubMed ID: 30958582
[TBL] [Abstract][Full Text] [Related]
11. Chemical genetic profiling of the microtubule-targeting agent peloruside A in budding yeast Saccharomyces cerevisiae.
Wilmes A; Hanna R; Heathcott RW; Northcote PT; Atkinson PH; Bellows DS; Miller JH
Gene; 2012 Apr; 497(2):140-6. PubMed ID: 22326528
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells.
Wilmes A; O'Sullivan D; Chan A; Chandrahasen C; Paterson I; Northcote PT; La Flamme AC; Miller JH
Cancer Chemother Pharmacol; 2011 Jul; 68(1):117-26. PubMed ID: 20848285
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.
Chan A; Singh AJ; Northcote PT; Miller JH
Invest New Drugs; 2015 Jun; 33(3):564-74. PubMed ID: 25822110
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization.
Hongo H; Kihara T; Kume T; Izumi Y; Niidome T; Sugimoto H; Akaike A
Biochem Biophys Res Commun; 2012 Sep; 426(1):94-9. PubMed ID: 22922102
[TBL] [Abstract][Full Text] [Related]
15. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells.
Ma XH; Duan WJ; Mo YS; Chen JL; Li S; Zhao W; Yang L; Mi SQ; Mao XL; Wang H; Wang Q
Brain Res; 2018 Jul; 1690():1-11. PubMed ID: 29596798
[TBL] [Abstract][Full Text] [Related]
17. A unique mode of microtubule stabilization induced by peloruside A.
Huzil JT; Chik JK; Slysz GW; Freedman H; Tuszynski J; Taylor RE; Sackett DL; Schriemer DC
J Mol Biol; 2008 May; 378(5):1016-30. PubMed ID: 18405918
[TBL] [Abstract][Full Text] [Related]
18. Cellular effects of the microtubule-targeting agent peloruside A in hypoxia-conditioned colorectal carcinoma cells.
Řehulka J; Annadurai N; Frydrych I; Znojek P; Džubák P; Northcote P; Miller JH; Hajdúch M; Das V
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1833-1843. PubMed ID: 28366502
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protects against apoptosis-related microtubule alterations in neuronal cells.
Nuydens R; Dispersyn G; Van Den Keiboom G; de Jong M; Connors R; Ramaekers F; Borgers M; Geerts H
Apoptosis; 2000 Feb; 5(1):43-51. PubMed ID: 11227490
[TBL] [Abstract][Full Text] [Related]
20. Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.
Chan A; Gilfillan C; Templeton N; Paterson I; Northcote PT; Miller JH
Invest New Drugs; 2017 Dec; 35(6):706-717. PubMed ID: 28733703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]